Navatx Nava builds RNA medicines beyond the liver, using modular lipid nanoparticles to deliver therapies precisely to the tissues and cells that need them.

Cosigns

Team

Funding

Total raised
$89M · as of 2026-07-01
Last valuation
Undisclosed
Series
Seed

Data current as of July 1, 2026